Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inel d.o.o - tehnecijum (99mtc) pertehnetat - radionuklidni generator - 2,15 gigabq/1 dan i sat kalibracije 43 gigabq/1 dan i sat kalibracije+ 1,9 gigabq/1 boca 38,1 gigabq/1 boca - 1 radionuklidni generator sadrži 2.1543 gigbq matičnog izotopa 99mo, koji je adsorbovan na hromatografskoj koloni; eluiranjem isporučuje 1.9038.10 gigbq 99mtc u obliku natrijumpertehnetat rastvora za injekciju; 99mtc se raspada uz emisiju gama zračenja sa prosječnom energijom 140 kev i vremenom poluraspada 6,01 sati

Europska Unija - hrvatski - EMA (European Medicines Agency)

corza medical gmbh - ljudskog fibrinogena, ljudskog trombina - hemostaza, kirurški - antihemorrhagics - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer animal health gmbh - iron(iii) ion, toltrazuril - толтразурил, kombinacije - svinje (prasadi) - za istovremenu prevenciju kliničkih simptoma кокцидиоза (kao što su proljev) novorođene prasadi na farmama sa potvrdio povijesti кокцидиоза uzrokovane cystoisospora суис i prevenciju anemije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

novo nordisk a/s - liraglutid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - Виктоза indiciran za liječenje odraslih, djece i adolescenata u dobi od 10 godina i više s nedovoljno kontroliranim dijabetesom tipa 2 kao dodatak prehrani i exerciseas, kada монотерапия метформина se smatra da je neprimjereno zbog netolerancije ili contraindicationsin i drugi lijekovi za liječenje šećerne bolesti. prema rezultatima istraživanja u vezi kombinacije, utjecaj na glikemijski kontrolu i kardiovaskularnih događaja, a u ispitivanih skupina.

Europska Unija - hrvatski - EMA (European Medicines Agency)

takeda pharma a/s - Брентуксимаб ведотин - lymphoma, non-hodgkin; hodgkin disease - antineoplastična sredstva - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). Адцетриса indiciran za liječenje odraslih pacijenata s relaps ili vatrostalne cd30+ limfom Ходжкина (ЛХ):nakon terapije, orfollowing barem dva do terapije nakon terapije ili мультиагентной kemoterapije-to nije opcija liječenja . sistem анапластическая крупноклеточная lymphomaadcetris u kombinaciji s ciklofosfamid, doksorubicin i prednizon (chp) je prikazana za odrasle pacijente s prethodno liječenih liječenje sistemske анапластической veliki stanica limfoma (salcl). Адцетриса indiciran za liječenje odraslih pacijenata s relaps ili vatrostalne salcl. kožni t-stanica lymphomaadcetris indiciran za liječenje odraslih bolesnika s cd30+ stanica kožni t limfom (ctcl), nakon što je najmanje 1 do sistemske terapije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastična sredstva - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Europska Unija - hrvatski - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Europska Unija - hrvatski - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

teva b.v. - doksorubicin hidroklorid - neoplazme dojki - antineoplastična sredstva - myocet liposomal, u kombinaciji s ciklofosfamid, dizajniran je za prvu liniju terapije метастатического raka dojke kod odraslih žena.

Europska Unija - hrvatski - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - imunosupresivi - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.